Table 3.

Distribution of patients according to the irritable bowel syndrome severity score classes n (%)

	Placebo (n = 25)	LCR35 (n = 25)
Baseline IBS severity score (V2)
150-300 (moderate symptoms)	25 (100.0)	25 (100.0)
Post-treatment IBS severity score (V3)
0-150 (mild symptoms)	12 (48.0)	8 (32.0)
150-300 (moderate symptoms)	8 (32.0)	13 (52.0)
> 300 (severe symptoms)	5 (20.0)	4 (16.0)
IBS severity score at the end of study (V4)
0-150 (mild symptoms)	9 (36.0)	6 (24.0)
150-300 (moderate symptoms)	8 (32.0)	13 (52.0)
> 300 (severe symptoms)	8 (32.0)	6 (24.0)

IBS: Irritable bowel syndrome.